Influence of HIV infection on the clinical presentation and outcome of adults with acute community-acquired pneumonia in Yaounde, Cameroon: a retrospective hospital-based study

BMC Pulmonary Medicine

Volumn 12, Issue , 2012, Pages

  Yone, Eric Walter P ^a,b   Balkissou, Adamou D ^b   Kengne, André P ^c   Kuaban, Christopher ^a,b  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^b Yaounde Jamot Hospital   (Cameroon)

^c SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

Cameroon; Community acquired pneumonia; HIV infection; Hospitalisation; Outcomes

Indexed keywords

HEMOGLOBIN;

ACUTE COMMUNITY ACQUIRED PNEUMONIA; ADOLESCENT; ADULT; ARTICLE; CAMEROON; COMMUNITY ACQUIRED PNEUMONIA; FEMALE; HEMOGLOBIN BLOOD LEVEL; HOSPITAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; TREATMENT FAILURE; TREATMENT RESPONSE;

ADULT; ANEMIA; CAMEROON; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HIV INFECTIONS; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PNEUMONIA; PREVALENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84869079902     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-12-46     Document Type: Article

References (24)

1. Koulla-Shiro S, Kuaban C, Belec L. Acute community-acquired bacterial pneumonia in Human Immunodeficiency Virus (HIV) infected and non-HIV-infected adult patients in Cameroon: aetiology and outcome. Tuber Lung Dis 1996, 77:47-51. 10.1016/S0962-8479(96)90075-1, 8733414.
2. Horo K, Koffi N, Kouassi B, N'gom AS, Kenmogné K, Ahui BJM, et al. Facteurs de décès par pneumopathie aiguë communautaire en milieu africain à Abidjan. Rev Pneumol Trop 2004, 1:10-13.
3. Horo K, Gode VC, Ahui JM, Kouassi AB, Djereke GB, Cardenat M, N'gom A, Koffi N, Aka-Danguy E. Pneumonies communautaires d'allure bactérienne chez le sujet infecté par le VIH : étude préliminaire prospective. Rev Pneumol Clin 2009, 65:137-142. 10.1016/j.pneumo.2009.03.004, 19524801.
4. Benito N, Moreno A, Miro MJ, Torres A. Pulmonary infections in HIV-infected patients: an update in the 21st century. ERJ Express 2011,
5. Cordero E, Pachón J, Rivero A, Girón JA, Gómez-Mateos J, Merino MD, Torres-Tortosa M, González-Serrano M, Aliaga L, Collado A, Hernández-Quero J, Barrera A, Nuño E. Community-acquired bacterial pneumonia in Enfermedades Infecciosas. Am J Respir Crit Care Med 2000, 162:2063-2068.
6. Christensen D, Feldman C, Rossi P, Marrie T, Blasi F, Luna C, Fernandez P, Porras J, Martinez J, Weiss K, Levy G, Lode H, Gross P, File T, Ramirez J. Community-Acquired Pneumonia Organization Investigators. HIV infection does not influence clinical outcomes in hospitalized patients with bacterial community-acquired pneumonia: results from the CAPO international cohort study. Clin Infect Dis 2005, 15:554-556.
7. Malinis M, Myers J, Bordon J, Peyrani P, Kapoor R, Nakamatzu R, Lopardo G, Torres A, Feldman C, Allen M, Arnold F, Ramirez J. Clinical outcomes of HIV-infected patients hospitalized with bacterial community-acquired pneumonia. Int J Infect Dis 2010, 14:e22-27.
8. Koffi N, N'gom A, Kouassi B, Aka-Danguy E, Tchamran MM. Les pneumopathies bactériennes à germes banals au cours de l'infection par le VIH chez l'adulte africain hospitalisé à Abidjan. Cote d'Ivoire Bull Soc Path Ex 1997, 90:370-372.
9. Van der Eerden MM, Vlaspolder F, De Graaff CS, Groot T, Bronsveld W, Jansen HM, Boersma WG. Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study. Thorax 2005, 60:672-768. 10.1136/thx.2004.030411, 1747487, 16061709.
10. Koffi N, N'gom A, Kouassi B, Horo K, Mansare L, Aka-Danguy E. Évaluation de l'antibiothérapie probabiliste dans les pneumopathies aiguës d'allure bactérienne hospitalisées en milieu africain . Bull Soc Pathol Exot 2001, 94:397-400.
11. Pefura Yone EW, Betyoumin AF, Kengne AP, Kaze Folefack FJ, Ngogang J. First-line antiretroviral therapy and dyslipidemia in people living with HIV-1 in Cameroon: a cross-sectional study. AIDS Res Ther 2011, 8:33. 10.1186/1742-6405-8-33, 3197472, 21943115.
12. Pefura Yone EW, Kengne AP, Kuaban C. Incidence, time and determinants of tuberculosis treatment default in Yaounde, Cameroon: a retrospective hospital register-based cohort study. BMJ open 2011, 1:e000289. 10.1136/bmjopen-2011-000289, 3225586, 22116091.
13. Bartlett JG, Dowell SF, Mandell LA, File TM, Musher DM, Fine JM. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis 2000, 31:347-382. 10.1086/313954, 10987697.
14. Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, Lewis SA, Macfarlane JT. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003, 58:377-382. 10.1136/thorax.58.5.377, 1746657, 12728155.
15. Ministry of Public Health Report on HIV sentinel surveillance system in Cameroon 1994, Yaoundé: Ministry of Public Health, Ministry of Public Health.
16. UNAIDS/WHO AIDS epidemic update 2008, http://data.unaids.org/pub/Report/2008/jc1535_annual_report07_fr.pdf, UNAIDS/WHO.
17. Sharma SK, Kadhiravan T, Banga A. A clinical prediction rule to identify patients with tuberculosis at high risk for HIV co-infection. Indian J Med Res 2009, 1:51-57.
18. Obirikorang C, Yeboah FA. Blood haemoglobin measurement as a predictive indicator for the progression of HIV/AIDS in resource-limited setting. J Biomed Sci 2009, 16:102. 10.1186/1423-0127-16-102, 2783029, 19922646.
19. Pefura Yone EW, Kuaban C, Afane Ze E, Simo L. Clinical characteristics, microbiologic findings and outcome of non-tuberculous purulent pleural effusion in HIV-infected and non HIV-infected adult patients in Yaounde, Cameroon. Rev Pneumol Clin 2011,
20. Feldman C, Glatthaar M, Morar R, Mahomed AG, Kaka S, Cassel M, Klugman KP. Bacteremic pneumococcal pneumonia in HIV-seropositive and HIV seronegative adults. Chest 1999, 116:107-114. 10.1378/chest.116.1.107, 10424512.
21. Johnson DH, Carriere KC, Houston S. Hospitalization for community- acquired pneumonia in Alberta patients with human immunodeficiency virus infection: a case control study. Can Respir J 2003, 10:265-270.
22. Falcó V, Fernández de Sevilla T, Alegre J, Barbé J, Ferrer A, Ocaña I, Ribera E, Martínez-Vázquez JM. Bacterial pneumonia in HIV-infected patients: a prospective study of 68 episodes. Eur Respir J 1994, 7:235-239. 10.1183/09031936.94.07020235, 8162975.
23. Mundy LM, Auwaerter PG, Oldach D, Warner ML, Burton A, Vance E, Gaydos CA, Joseph JM, Gopalan R, Moore RD. Community acquired pneumonia: impact of immune status. Am J Respir Crit Care Med 1995, 152:1309-1315.
24. Feldman C, Klugman KP, Yu VL, Ortqvist A, Choiu CC, Chedid MB, Rello J, Wagener M. Bacteraemic pneumococcal pneumonia: impact of HIV on clinical presentation and outcome. J Infect 2007, 55:125-135. 10.1016/j.jinf.2007.04.001, 17524486.